Two Seas Capital, which holds a 6.3% equity stake in Core Scientific, stated it will oppose the Board of Directors’ current deal with CoreWeave. The investment firm believes the $9 billion valuation undervalues Core Scientific’s position in the high-performance compute space.
Further, Two Seas argues that the all-equity structure of the deal exposes shareholders to CoreWeave’s stock volatility without offering any downside protection. It also cited the immediate 30% drop in Core Scientific’s share price after the deal was announced as evidence that the market shares its concerns.
You might also like: AI is being built behind closed doors, and that’s a dangerous mistake | Opinion
Two Seas Capital against any Core Scientific sale
Two Seas Capital has presented itself as a committed investor and an advocate of Core Scientific since 2022. The company is an active investor and has also raised its equity stake since then.
You might also like: Exclusive: Vitalik Buterin’s take on the ‘AI versus humans’ debate
Moreover, the investment firm stated that it’s not opposed to a CoreWeave merger as such. In fact, the firm also owns CoreWeave shares. It is just opposed to the merger at the current valuation.
Originally launched as a Bitcoin mining firm, Core Scientific capitalized on the crypto bull market and went public in January 2022 at a $4.3 billion valuation. However, the subsequent market downturn led to bankruptcy and a strategic shift toward AI compute infrastructure.
You might also like: AI could destroy crypto within five years | Opinion